ACS:180 AND ADVIA CENTAUR B-TYPE NATRIURETIC PEPTIDE (BNP) ASSAYS

Test, Natriuretic Peptide

BAYER HEALTHCARE, LLC

The following data is part of a premarket notification filed by Bayer Healthcare, Llc with the FDA for Acs:180 And Advia Centaur B-type Natriuretic Peptide (bnp) Assays.

Pre-market Notification Details

Device IDK040425
510k NumberK040425
Device Name:ACS:180 AND ADVIA CENTAUR B-TYPE NATRIURETIC PEPTIDE (BNP) ASSAYS
ClassificationTest, Natriuretic Peptide
Applicant BAYER HEALTHCARE, LLC 511 BENEDICT AVE. Tarrytown,  NY  10591
ContactKenneth T Edds
CorrespondentKenneth T Edds
BAYER HEALTHCARE, LLC 511 BENEDICT AVE. Tarrytown,  NY  10591
Product CodeNBC  
CFR Regulation Number862.1117 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2004-02-18
Decision Date2004-06-14
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.